For the Fukuoka Blood and Marrow Transplantation Group

Granulocyte colony-stimulating factor-induced mobilization of peripheral blood stem cells for autologous and allogeneic transplantation

K. Akashi, K. Takenaka, S. Inaba, 1996, Cancer Chemotherapy and Pharmacology.

Risk of secondary primary malignancies in multiple myeloma patients with or without autologous stem cell transplantation

K. Akashi, H. Iwasaki, S. Yamasaki, 2018, International Journal of Hematology.

Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission: a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group

T. Naoe, T. Uchida, K. Miyamura, 2008, International journal of hematology.

Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients

K. Akashi, K. Takenaka, T. Miyamoto, 2009, International journal of hematology.

Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of relapse

T. Naoe, M. Kasai, K. Miyamura, 2015, Annals of Hematology.

Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma

K. Akashi, H. Iwasaki, S. Yamasaki, 2020, International Journal of Hematology.

Factors prognostic of eligibility for allogeneic HCT among older patients with AML-CR1 and adverse- or intermediate-risk cytogenetics

K. Akashi, S. Yamasaki, T. Miyamoto, 2015, Annals of Hematology.

A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients

J. Singer, J. Bianco, J. Singer, 2000, Bone Marrow Transplantation.